Reports Q3 revenue $1.2B, consensus $1.64B. “Our focus on execution continues to drive growth, with significant opportunity ahead,” said Brent Saunders, chairman and CEO, Bausch + Lomb (BLCO). “We’re in the middle of multi-dimensional launch cycles around the world, covering all our businesses and targeting all our audiences.”
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLCO:
- Bausch Health price target raised to $10 from $8.50 at RBC Capital
- Bausch + Lomb price target raised to $23 from $20 at RBC Capital
- Banks competing to fund possible Bausch + Lomb buyout, Bloomberg says
- Etsy, Enphase downgraded: Wall Street’s top analyst calls
- Bausch + Lomb upgraded to Outperform from In Line at Evercore ISI